Delivery Order SPE2DB20D3104-SPE2DB24FV7W9

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FG4W9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,804.58, is for the delivery of 4565213366 - LIDOCAINE 5% PATCH 30S. It is a firm fixed-price delivery order contract with a completion date of July 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
This federal contract award, valued at $3,249.75, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of March 6, 2024. This is a firm fixed-price delivery order contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,456.11, is a Firm Fixed Price Delivery Order for the supply of LIDOCAINE 5% PATCH 30S. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,998.82 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, SPE2DB22D3301|SPE2DB25FX8HD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566895805 - LIDOCAINE 5% PATCH 30S. The contract has a firm fixed price of $2,982.84 and a completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, with ID SPE2DB22D1002|SPE2DB24FLEL3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4565068463 - LIDOCAINE 5% PATCH 30S medical supplies, with a firm fixed price ceiling value of $1,036.63 and a completion date of July 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB20D3103|SPE2DB25FL7M1, is a Delivery Order valued at $5,147.80 with a Firm Fixed Price pricing type. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, with a completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FB9A3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,110.09, is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The contract is a firm fixed-price delivery order, with a completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,612.69 firm fixed-price delivery order contract is for the provision of LIDOCAINE 5% PATCH 30S, a medical commodity supporting military healthcare programs. The contract has an ultimate completion date of December 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $7,231.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a firm fixed-price delivery order contract type, is for the supply of 4565266540 - LIDOCAINE 5% PATCH 30S medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV7W9
    Delivery Order

This federal contract award, SPE2DB20D3104|SPE2DB24FV7W9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $3,261.95, is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The contract has an ultimate completion date of July 1, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award was not designated with a set-aside requirement, indicating open competition. The contract type is Delivery Order with a Firm Fixed Price pricing type.

Generated 5/17/25, 10:02 AM